Jam

MicroCloud Hologram Inc. introduces a quantum spectral filter for hybrid graph neural networks. This technology maps graph Laplacian operators to trainable quantum circuits, enabling exponential compression of graph signals. It fuses convolution and pooling into a single quantum process, drastically reducing computational needs for large graphs. The innovation promises significant advancements in processing complex data structures, particularly for large-scale graph learning applications.

374Water Inc. has appointed real estate veteran Bradley R. Freels to its Board of Directors. Freels, CEO of Midway, brings extensive experience in real estate development, investment, and early-stage company financing. His expertise is expected to drive the commercialization of 374Water’s AirSCWO technology and support the company’s strategic growth initiatives. Freels, an early supporter of 374Water, aims to leverage the technology for sustainable development and positive impacts across various sectors.

Teads has appointed Dani Cushion as Chief Marketing Officer to lead global marketing initiatives and drive expansion. With a background in leading marketing for major tech and media firms, including Innovid and Cardlytics, Cushion is expected to accelerate Teads’ growth and enhance advertiser outcomes within the evolving ad tech landscape, particularly in Connected TV. This strategic hire supports Teads’ focus on strengthening its leadership and omnichannel platform.

Himax Technologies reaffirms its strong partnership with FOCI on Co-Packaged Optics (CPO). Their joint development leverages Himax’s WLO nano imprinting technology with FOCI’s silicon photonics expertise. The first-generation CPO solution is undergoing customer validation for mass production in 2026. Future efforts focus on next-generation high-speed optical transmission for AI data centers and HPC. This collaboration highlights Himax’s strategic expansion into advanced optical technologies.

Autoliv and Tensor have unveiled the first foldable steering wheel for the Tensor Robocar, set for production in late 2026. This innovative system retracts for fully autonomous mode, transforming the cabin into a versatile space, and deploys for manual driving with adaptive airbag safety. This technology aims to enhance both user experience and safety in the evolving autonomous vehicle landscape.

FUTR and Realbotix have partnered to integrate FUTR’s AI Agents with Realbotix’s humanoid robots, bringing digital intelligence into the physical realm. This collaboration allows users to connect their FUTR AI Agent to a physical robot for more intuitive interactions, voice commands, and secure data/task execution via FUTR’s payment infrastructure. The pilot program aims to enhance user engagement and explore commercial opportunities for physical AI.

LG Display is set to unveil advanced OLED technologies at CES 2026, focusing on AI and automotive sectors. Innovations include a new OLED TV panel with 4,500 nits brightness and a 720Hz gaming monitor. For automotive, they will showcase a 51-inch Pillar-to-Pillar display and a flexible Slidable OLED concept, reinforcing their leadership in display solutions.

HUTCHMED has advanced its pancreatic cancer program to Phase III, initiating a trial for a combination therapy of surufatinib, camrelizumab, nab-paclitaxel, and gemcitabine (S+C+AG) for metastatic PDAC in China. Promising Phase II results showed significant improvements in progression-free survival and objective response rate compared to the standard chemotherapy regimen. The Phase III trial will evaluate overall survival as the primary endpoint in approximately 400 additional patients.

Crinetics Pharmaceuticals will host an investor call on January 5th, 2026, to discuss PALSONIFY’s commercialization strategy and present topline Phase 2 data for atumelnant in congenital adrenal hyperplasia. Management will provide updates on their go-to-market plan for PALSONIFY and share results from the fourth cohort of the atumelnant trial, offering insights into the company’s pipeline and future prospects.

Sinovac Biotech has provided a governance update. The Antigua High Court has appointed a new board slate, with Ms. Rui-Ping Xiao stepping down. All audit, compensation, and governance committees remain independent. Additionally, Zhonghua Certified Public Accountants LLP has been appointed as the new independent auditor, effective December 31, 2025, to enhance financial reporting and compliance.